Mar 03,2022

Reality check: Real-world evidence to support therapeutic development in hematologic malignancies

In this article in the scientific journal Blood Reviews, COTA researchers and collaborators share their views on the many sources of RWD and how to assess fit-for-purpose for use in RWE generation. They also review promising use cases for RWD, particularly for hematologic malignancies.

CLINICAL STUDY

#rwd

#rwe

View Analyst & Ambassador Comments
Go to original news
May 18,2022

Miami Cancer Institute Takes Action To Address Inequities in Cancer Care with Expanded COTA, Inc. Collaboration

COTA, Inc. and Miami Cancer Institute, part of Baptist Health South Florida, announced today they are expanding their real-world data (RWD) and analytics partnership. Miami Cancer Institute will use COTA’s Real-World Analytics platform (RWA) to better understand how certain patient demographics, such as zip code, ethnicity, or other socio-economic factors, contribute to unwanted disparities in patient outcomes.

COLLABORATION PARTNERSHIP

#institution

#rwd

#rwe

View Analyst & Ambassador Comments
Go to original news
Jun 09,2022

AdhereTech and Massive Bio Announce AI-Enabled, Patient-Centric Oncology Solutions Partnership

Massive Bio, Inc., a leader in precision medicine and artificial intelligence (AI)-enabled patient-centric clinical trial enrollment for oncology, and AdhereTech, a leading provider of smart devices that connect patients to care with real-time interventions, announced their partnership to provide advanced, data-driven digital health technology solutions, focusing in oral oncolytic agents providing real-time integrated access to care for cancer patients to precision oncology drugs and leading-edge clinical trials. Massive Bio and AdhereTech have committed to combining their products and services to offer global, comprehensive solutions to measure, analyze and monitor precision oncology medication adherence for patients participating in clinical trials and those prescribed commercially available treatments.

COLLABORATION PARTNERSHIP

#product & service

#rwd

#rwe

View Analyst & Ambassador Comments
Go to original news
Sep 14,2022

RCTs and RWD: What are They and How do They Complement Each Other in Cancer Research?

Real world data (RWD) is transforming clinical development and it is critical to understand how RWD and randomized clinical trials (RCTs) can work together to bring life saving medicines to patients faster. In this new blog series from COTA and Deloitte, they explore the expanding role of RWD in oncology.

#rwd

#rwe

View Analyst & Ambassador Comments
Go to original news
Mar 08,2021

Vinehealth named one of 12 high impact innovations to join the NHS England’s National Innovation Accelerator in 2021

The NHS Innovation Accelerator (NIA) announces the 12 innovators and innovations selected to join its award-winning programme in 2021. These innovations offer solutions to some of the NHS’ most pressing needs and will be supported over the next three years to scale across England for the benefit of NHS patients and staff. Vinehealth is delighted to have been successfully selected for the 2021 cohort. The next step for the Company is to undertake projects across the UK which Vinehealth is excited to be working collaboratively with the Academic Health Science Networks (AHSN )to deliver.

COLLABORATION PARTNERSHIP

#r&d

#mobile app

#rwe

View Analyst & Ambassador Comments
Go to original news
Mar 01,2021

Flatiron Health Research Characterizes Real-World Response & Associated Endpoint in Oncology

Flatiron Health has announced the publication of research showing that curation of de-identified electronic health record (EHR)-derived data can be used to generate a reliable real-world response (rwR) variable and associated endpoint in oncology. Real-world treatment effectiveness measures are needed to generate real-world evidence (RWE) that may support development and regulatory decision-making.

CLINICAL STUDY

#rwe

View Analyst & Ambassador Comments
Go to original news
Mar 16,2021

COTA, Inc. and Kite Collaborate To Expand the Use of Real-World Data To Drive Faster, Effective Treatments for Cancers

COTA, Inc., an oncology real-world data and analytics company, today announced a collaboration with Kite, a Gilead company, through which COTA’s real-world data will be used to accelerate Kite’s drug development pipeline. This approach will help inform decisions about future therapeutic applications for blood cancers while inspiring new ways of thinking about how clinical trials are designed.

COLLABORATION PARTNERSHIP

#r&d

#rwd

#rwe

View Analyst & Ambassador Comments
Go to original news
Mar 18,2021

Broward Health and Voluntis launch a new clinical evaluation program on digital therapeutics for metastatic breast cancer

Voluntis, a leader in digital therapeutics, announced today a collaboration with Broward Health, a public health system in the U.S. The partnership will focus on conducting a real-world evaluation of Oleena, a digital application that assists patients in managing their symptoms. As part of the collaboration, Oleena, a FDA-authorized digital therapeutic application developed by Voluntis for patients with cancer, will be provided to patients with HR+/HER2- metastatic breast cancer to support them in self-managing symptoms and side effects of their conditions and treatments

COLLABORATION PARTNERSHIP

#institution

#dtx

#rwe

View Analyst & Ambassador Comments
Go to original news
May 01,2021

Leading Real-World Data and Analytics Organizations Form Industry Coalition to Advance Policies to Support Regulatory Use of Real-World Evidence

Five real-world data (RWD) and analytics organizations today announced an industry coalition dedicated to advancing the use of real-world evidence (RWE) to support regulatory decisions. Founding members of the RWE Alliance are Aetion, Flatiron Health, IQVIA, Syapse, and Tempus.

#rwd

#rwe

View Analyst & Ambassador Comments
Go to original news
Jul 16,2021

COTA and MedStar Health Partner To Drive Scientific Research and Expedite Delivery of Innovative Cancer Treatments

COTA, Inc., an oncology real-world data and analytics company, announced a new research partnership with MedStar Health. COTA will support MedStar Health in its use of real-world data to accelerate scientific discovery and improve care for cancer patients. COTA provides comprehensive oncology real-world data abstraction, curation, and analytics capabilities to leading healthcare provider organizations and life sciences companies that are caring and developing treatments for patients living with a wide range of cancers.

COLLABORATION PARTNERSHIP

#institution

#rwd

#rwe

View Analyst & Ambassador Comments
Go to original news
Subscribe to RWE